Altimmune Inc (ALT)
8.40
+0.35
(+4.35%)
USD |
NASDAQ |
Nov 21, 16:00
8.51
+0.11
(+1.31%)
After-Hours: 19:04
Altimmune Price to Book Value: 4.479 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 4.293 |
| November 19, 2024 | 3.984 |
| November 18, 2024 | 3.813 |
| November 15, 2024 | 4.058 |
| November 14, 2024 | 4.509 |
| November 13, 2024 | 5.077 |
| November 12, 2024 | 5.061 |
| November 11, 2024 | 3.920 |
| November 08, 2024 | 4.095 |
| November 07, 2024 | 3.978 |
| November 06, 2024 | 3.898 |
| November 05, 2024 | 3.749 |
| November 04, 2024 | 3.621 |
| November 01, 2024 | 3.594 |
| October 31, 2024 | 3.594 |
| October 30, 2024 | 3.605 |
| October 29, 2024 | 3.925 |
| October 28, 2024 | 3.738 |
| October 25, 2024 | 3.568 |
| October 24, 2024 | 3.608 |
| October 23, 2024 | 3.584 |
| October 22, 2024 | 3.626 |
| October 21, 2024 | 3.680 |
| October 18, 2024 | 3.669 |
| October 17, 2024 | 3.621 |
| Date | Value |
|---|---|
| October 16, 2024 | 3.658 |
| October 15, 2024 | 3.754 |
| October 14, 2024 | 3.429 |
| October 11, 2024 | 3.360 |
| October 10, 2024 | 3.210 |
| October 09, 2024 | 3.258 |
| October 08, 2024 | 3.328 |
| October 07, 2024 | 3.253 |
| October 04, 2024 | 3.322 |
| October 03, 2024 | 3.280 |
| October 02, 2024 | 3.344 |
| October 01, 2024 | 3.354 |
| September 30, 2024 | 3.274 |
| September 27, 2024 | 3.015 |
| September 26, 2024 | 3.173 |
| September 25, 2024 | 3.262 |
| September 24, 2024 | 3.318 |
| September 23, 2024 | 3.355 |
| September 20, 2024 | 3.630 |
| September 19, 2024 | 3.527 |
| September 18, 2024 | 3.462 |
| September 17, 2024 | 3.527 |
| September 16, 2024 | 3.532 |
| September 13, 2024 | 3.672 |
| September 12, 2024 | 3.308 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.5032
Minimum
Nov 22 2019
13.39
Maximum
Jul 20 2020
2.528
Average
2.194
Median
Price to Book Value Benchmarks
| Eli Lilly and Co | 49.99 |
| Viking Therapeutics Inc | 6.316 |
| Amgen Inc | 20.70 |
| Avid Bioservices Inc | 13.33 |
| NovaBay Pharmaceuticals Inc | 3.291 |
Price to Book Value Related Metrics
| PS Ratio | 10956.78 |
| PEG Ratio | -2.747 |
| Price | 8.40 |
| Earnings Yield | -18.69% |
| Market Cap | 597.45M |